Key result
Maternal midpregnancy blood glucose levels were strongly associated with increased odds of tetralogy of Fallot in offspring (adjusted OR 7.54; 95% CI, 2.30-24.69).
Why the study?
Do maternal midpregnancy glucose and insulin levels increase the risk of specific congenital heart diseases in offspring?
Population
277 pregnant women in southern and central California carrying infants with tetralogy of Fallot…
Comparison
Maternal midpregnancy measures of glucose and… vs Maternal midpregnancy measures in women carrying…
Design
Case-control
Authors
Loading...
Should not yet change prenatal glucose management; leaves open causal links to specific congenital heart defects.
Case-Control (n=277)
Do maternal midpregnancy glucose and insulin levels increase the risk of specific congenital heart diseases in offspring?
Odds Ratio: 7.54 (95% CI 2.3–24.69)
Elevated maternal midpregnancy glucose levels are strongly associated with increased odds of tetralogy of Fallot in offspring, suggesting subclinical glucose abnormalities may confer risk for specific congenital heart diseases.
Priest et al. (2015) conducted a case-control in Congenital heart disease in offspring (n=277). Maternal midpregnancy glucose levels vs. Maternal midpregnancy glucose levels of healthy infants without CHD was evaluated on Odds of tetralogy of Fallot (TOF) (adjusted OR 7.54, 95% CI 2.30-24.69). Maternal midpregnancy blood glucose levels were strongly associated with increased odds of tetralogy of Fallot in offspring (adjusted OR 7.54; 95% CI, 2.30-24.69).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: